A GFP-Tagged Gross Deletion on Chromosome 1 Causes Malignant Peripheral Nerve Sheath Tumors and Carcinomas in

Matteo Astone1, Marco Pizzi2, Margherita Peron1

  • 1Department of Biology, University of Padova, Padova, Italy.

Plos One
|December 24, 2015
PubMed

Insights

A new zebrafish model, Tg(-8.5nkx2.2a:GFP)ia2, enables high-frequency study of malignant peripheral nerve sheath tumors (MPNSTs). This model reveals genetic deletions and potential drivers, aiding cancer research.

Area of Science:

  • Oncology
  • Genetics
  • Zebrafish models

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft-tissue sarcomas with poorly understood molecular drivers.
  • Current targeted therapies for MPNSTs are limited, necessitating new research models.

Purpose of the Study:

  • To develop and characterize a novel zebrafish model for studying MPNST biology and genetics.
  • To investigate the genetic underpinnings of MPNST development in the new zebrafish model.

Main Methods:

  • Generation of the transgenic zebrafish line Tg(-8.5nkx2.2a:GFP)ia2.
  • Histological and immunohistochemical analysis of tumor development in adult heterozygotes.
  • Microsatellite (VNTR) and STS marker analysis to identify genetic alterations associated with the ia2 insertion.

Main Results:

  • Tg(-8.5nkx2.2a:GFP)ia2 heterozygotes developed high-frequency MPNSTs with mesenchymal or epithelial features.
  • Mesenchymal tumors showed characteristics consistent with zebrafish MPNSTs.
  • Genetic analysis revealed a 15.2 Mb deletion on chromosome 1, including the 40S ribosomal protein S6 gene, in ia2 mutants.

Conclusions:

  • The Tg(-8.5nkx2.2a:GFP)ia2 zebrafish line serves as a valuable tool for in vivo MPNST research.
  • The identified deletion and potential driver genes offer insights into MPNST pathogenesis.
  • This model facilitates the study of conserved cancer mechanisms in zebrafish and humans.

Related Concept Videos